{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:12:53Z","timestamp":1760141573538,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejso.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:49:26Z","timestamp":1662637766000},"page":"475-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery"],"prefix":"10.1016","volume":"49","author":[{"given":"Xi-Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Er","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Na","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Leng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-2110","authenticated-orcid":false,"given":"Da-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.09.004_bib1","first-page":"7","article-title":"Cancer statistics, 2022.[J]","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2022.09.004_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.[J]","volume":"116","author":"Lewin","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejso.2022.09.004_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/gyno.2002.6789","article-title":"Stage IIIC endometrioid corpus cancer includes distinct subgroups","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib4","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","article-title":"Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy","volume":"75","author":"Onda","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.05.002","article-title":"Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.[J]","volume":"154","author":"Chapman","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2017.08.031","article-title":"Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.[J]","volume":"147","author":"Binder","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2020.04.012","article-title":"Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: a population-based study.[J]","volume":"133","author":"van Weelden","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib8","article-title":"Lymph node number predicts the efficacy of adjuvant chemoradiotherapy in node-positive endometrial cancer patients.[J]","volume":"10","author":"Lee","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ejso.2022.09.004_bib9","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.2217\/fon-2020-1308","article-title":"Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy.[J]","volume":"17","author":"Onal","year":"2021","journal-title":"Future Oncol"},{"issue":"Suppl 23","key":"10.1016\/j.ejso.2022.09.004_bib10","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/cncr.29049","article-title":"The surveillance, Epidemiology, and End results (SEER) program of the national cancer institute","volume":"120","author":"Cronin","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib11","article-title":"Comparison of different lymph node staging schemes for predicting survival outcomes in node-positive endometrioid endometrial cancer patients.[J]","volume":"8","author":"Yang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejso.2022.09.004_bib12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ejso.2021.12.462","article-title":"Construction and validation of a prognostic model for stage IIIC endometrial cancer patients after surgery.[J]","volume":"48","author":"Yang","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2011.02.040","article-title":"Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome.[J]","volume":"122","author":"Wright","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/ijgc-2020-002158","article-title":"Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer.[J]","volume":"31","author":"Narasimhulu","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/ijgc-2021-002450","article-title":"The impact of sentinel lymph node sampling versus traditional lymphadenectomy on the survival of patients with stage IIIC endometrial cancer.[J]","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/gyno.2001.6157","article-title":"Analysis of FIGO Stage IIIc endometrial cancer patients.[J]","volume":"81","author":"McMeekin","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.[J]","volume":"20","author":"De Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib19","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejso.2022.09.004_bib20","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.3802\/jgo.2018.29.e48","article-title":"Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study","volume":"29","author":"Ayhan","year":"2018","journal-title":"J.\u00a0Gynecol. Oncol."},{"key":"10.1016\/j.ejso.2022.09.004_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/IGC.0000000000000510","article-title":"Impact of lymph node ratio and adjuvant therapy in node-positive endometrioid endometrial cancer.[J]","volume":"25","author":"Fleming","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2022.09.004_bib23","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2022.09.004_bib24","article-title":"HER2 status in high-risk endometrial cancers (PORTEC-3): relationship with histotype, molecular classification, and clinical outcomes","volume":"13","author":"Vermij","year":"2020","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.ejso.2022.09.004_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2018.07.020","article-title":"Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: evaluation of the pilot phase of the PORTEC-4a trial.[J]","volume":"151","author":"Wortman","year":"2018","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:42Z","timestamp":1760060862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0748798322006552"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.09.004","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}